|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q63986268
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010726.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q63986268
|
|
024
|
|
|
‡a
0000-0001-9884-4751
‡2
orcid
|
|
024
|
|
|
‡a
7201413997
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q63986268
|
|
100
|
0 |
|
‡a
Marcia Carvalho
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Marcia Carvalho
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's 3,4-Methylenedioxymethamphetamine Hepatotoxicity under the Heat Stress Condition: Novel Insights from in Vitro Metabolomic Studies
|
|
670
|
|
|
‡a
Author's A Panel of Urinary Volatile Biomarkers for Differential Diagnosis of Prostate Cancer from Other Urological Cancers
|
|
670
|
|
|
‡a
Author's A rapid and simple procedure for the establishment of human normal and cancer renal primary cell cultures from surgical specimens.
|
|
670
|
|
|
‡a
Author's Adipokine Gene Single-Nucleotide Polymorphisms in Portuguese Obese Adolescents: Associations with Plasma Concentrations of Adiponectin, Resistin, IL-6, IL-1β, and TNF-α.
|
|
670
|
|
|
‡a
Author's Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes
|
|
670
|
|
|
‡a
Author's Analysis of volatile human urinary metabolome by solid-phase microextraction in combination with gas chromatography–mass spectrometry for biomarker discovery: Application in a pilot study to discriminate patients with renal cell carcinoma
|
|
670
|
|
|
‡a
Author's Biological activities of Portuguese propolis: protection against free radical-induced erythrocyte damage and inhibition of human renal cancer cell growth in vitro.
|
|
670
|
|
|
‡a
Author's Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies
|
|
670
|
|
|
‡a
Author's Chiral enantioresolution of cathinone derivatives present in "legal highs", and enantioselectivity evaluation on cytotoxicity of 3,4-methylenedioxypyrovalerone (MDPV)
|
|
670
|
|
|
‡a
Author's Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS.
|
|
670
|
|
|
‡a
Author's Environmental and biological monitoring of benzene, toluene, ethylbenzene and xylene (BTEX) exposure in residents living near gas stations
|
|
670
|
|
|
‡a
Author's Evaluation of free radical-scavenging and antihemolytic activities of quince
|
|
670
|
|
|
‡a
Author's Evaluation of free radical-scavenging and antihemolytic activities of quince (Cydonia oblonga) leaf: a comparative study with green tea (Camellia sinensis).
|
|
670
|
|
|
‡a
Author's Evaluation of GSH adducts of adrenaline in biological samples
|
|
670
|
|
|
‡a
Author's Exposure to BTEX in buses: The influence of vehicle fuel type
|
|
670
|
|
|
‡a
Author's Further insights into chemical characterization through GC–MS and evaluation for anticancer potential of Dracaena draco leaf and fruit extracts
|
|
670
|
|
|
‡a
Author's GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
|
|
670
|
|
|
‡a
Author's GC-MS Metabolomics Reveals Distinct Profiles of Low- and High-Grade Bladder Cancer Cultured Cells
|
|
670
|
|
|
‡a
Author's GC-MS metabolomics reveals disturbed metabolic pathways in primary mouse hepatocytes exposed to subtoxic levels of 3,4-methylenedioxymethamphetamine (MDMA)
|
|
670
|
|
|
‡a
Author's Hepatic Metabolic Derangements Triggered by Hyperthermia: An In Vitro Metabolomic Study
|
|
670
|
|
|
‡a
Author's Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine
|
|
670
|
|
|
‡a
Author's In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV)
|
|
670
|
|
|
‡a
Author's In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV)
|
|
670
|
|
|
‡a
Author's Metabolic signature of methylone in primary mouse hepatocytes, at subtoxic concentrations
|
|
670
|
|
|
‡a
Author's Methylone and MDPV activate autophagy in human dopaminergic SH-SY5Y cells: a new insight into the context of β-keto amphetamines-related neurotoxicity.
|
|
670
|
|
|
‡a
Author's Neurotoxicity of β-Keto Amphetamines: Deathly Mechanisms Elicited by Methylone and MDPV in Human Dopaminergic SH-SY5Y Cells.
|
|
670
|
|
|
‡a
Author's New findings on urinary prostate cancer metabolome through combined GC-MS and 1H NMR analytical platforms
|
|
670
|
|
|
‡a
Author's Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.
|
|
670
|
|
|
‡a
Author's Optimisation and validation of a HS-SPME–GC–IT/MS method for analysis of carbonyl volatile compounds as biomarkers in human urine: Application in a pilot study to discriminate individuals with smoking habits
|
|
670
|
|
|
‡a
Author's Recent Patents on Camellia sinensis: Source of Health Promoting Compounds
|
|
670
|
|
|
‡a
Author's Renal cell carcinoma: a critical analysis of metabolomic biomarkers emerging from current model systems.
|
|
670
|
|
|
‡a
Author's Simultaneous determination of amphetamine derivatives in human urine after SPE extraction and HPLC-UV analysis.
|
|
670
|
|
|
‡a
Author's Sunitinib versus Pazopanib Dilemma in Renal Cell Carcinoma: New Insights into the In Vitro Metabolic Impact, Efficacy, and Safety
|
|
670
|
|
|
‡a
Author's The hallucinogenic world of tryptamines: an updated review
|
|
670
|
|
|
‡a
Author's Toxicometabolomics: Small Molecules to Answer Big Toxicological Questions
|
|
670
|
|
|
‡a
Author's Update on 1-benzylpiperazine (BZP) party pills.
|
|
670
|
|
|
‡a
Author's Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography–mass spectrometry
|
|
670
|
|
|
‡a
Author's Καρκίνωμα νεφρικών κυττάρων: μια κριτική ανάλυση μεταβολικών βιοδεικτών που προκύπτουν από τα τρέχοντα μοντέλα συστημάτων.
|
|
909
|
|
|
‡a
(scopus) 7201413997
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000198844751
‡9
1
|
|
919
|
|
|
‡a
furtherinsightsintochemicalcharacterizationthroughgcmsandevaluationforanticancerpotentialofdracaenadracoleafandfruitextracts
‡A
Further insights into chemical characterization through GC–MS and evaluation for anticancer potential of Dracaena draco leaf and fruit extracts
‡9
1
|
|
919
|
|
|
‡a
neurotoxicityofβketoamphetaminesdeathlymechanismselicitedbymethyloneandmdpvinhumandopaminergicshsy5ycells
‡A
Neurotoxicity of β-Keto Amphetamines: Deathly Mechanisms Elicited by Methylone and MDPV in Human Dopaminergic SH-SY5Y Cells.
‡9
1
|
|
919
|
|
|
‡a
newfindingsonurinaryprostatecancermetabolomethroughcombinedgcmsand1hnmranalyticalplatforms
‡A
New findings on urinary prostate cancer metabolome through combined GC-MS and 1H NMR analytical platforms
‡9
1
|
|
919
|
|
|
‡a
methyloneandmdpvactivateautophagyinhumandopaminergicshsy5ycellsanewinsightintothecontextofβketoamphetaminesrelatedneurotoxicity
‡A
Methylone and MDPV activate autophagy in human dopaminergic SH-SY5Y cells: a new insight into the context of β-keto amphetamines-related neurotoxicity.
‡9
1
|
|
919
|
|
|
‡a
nuclearmagneticresonancemetabolomicsrevealsanexcretorymetabolicsignatureofrenalcellcarcinoma
‡A
Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.
‡9
1
|
|
919
|
|
|
‡a
gcmsmetabolomicsbasedapproachfortheidentificationofapotentialvocbiomarkerpanelintheurineofrenalcellcarcinomapatients
‡A
GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
‡9
1
|
|
919
|
|
|
‡a
gcmsmetabolomicsrevealsdistinctprofilesoflowandhighgradebladdercancerculturedcells
‡A
GC-MS Metabolomics Reveals Distinct Profiles of Low- and High-Grade Bladder Cancer Cultured Cells
‡9
1
|
|
919
|
|
|
‡a
gcmsmetabolomicsrevealsdisturbedmetabolicpathwaysinprimarymousehepatocytesexposedtosubtoxiclevelsof34methylenedioxymethamphetaminemdma
‡A
GC-MS metabolomics reveals disturbed metabolic pathways in primary mouse hepatocytes exposed to subtoxic levels of 3,4-methylenedioxymethamphetamine (MDMA)
‡9
1
|
|
919
|
|
|
‡a
hepaticmetabolicderangementstriggeredbyhyperthermiaaninvitrometabolomicstudy
‡A
Hepatic Metabolic Derangements Triggered by Hyperthermia: An In Vitro Metabolomic Study
‡9
1
|
|
919
|
|
|
‡a
identificationofabiomarkerpanelforimprovementofprostatecancerdiagnosisbyvolatilemetabolicprofilingofurine
‡A
Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine
‡9
1
|
|
919
|
|
|
‡a
exposuretobtexinbusestheinfluenceofvehiclefueltype
‡A
Exposure to BTEX in buses: The influence of vehicle fuel type
‡9
1
|
|
919
|
|
|
‡a
optimisationandvalidationofahsspmegcitmsmethodforanalysisofcarbonylvolatilecompoundsasbiomarkersinhumanurineapplicationinapilotstudytodiscriminateindividualswithsmokinghabits
‡A
Optimisation and validation of a HS-SPME–GC–IT/MS method for analysis of carbonyl volatile compounds as biomarkers in human urine: Application in a pilot study to discriminate individuals with smoking habits
‡9
1
|
|
919
|
|
|
‡a
recentpatentsoncamelliasinensissourceofhealthpromotingcompounds
‡A
Recent Patents on Camellia sinensis: Source of Health Promoting Compounds
‡9
1
|
|
919
|
|
|
‡a
renalcellcarcinomaacriticalanalysisofmetabolomicbiomarkersemergingfromcurrentmodelsystems
‡A
Renal cell carcinoma: a critical analysis of metabolomic biomarkers emerging from current model systems.
‡9
1
|
|
919
|
|
|
‡a
simultaneousdeterminationofamphetaminederivativesinhumanurineafterspeextractionandhplcuvanalysis
‡A
Simultaneous determination of amphetamine derivatives in human urine after SPE extraction and HPLC-UV analysis.
‡9
1
|
|
919
|
|
|
‡a
evaluationofgshadductsofadrenalineinbiologicalsamples
‡A
Evaluation of GSH adducts of adrenaline in biological samples
‡9
1
|
|
919
|
|
|
‡a
sunitinibversuspazopanibdilemmainrenalcellcarcinomanewinsightsintotheinvitrometabolicimpactefficacyandsafety
‡A
Sunitinib versus Pazopanib Dilemma in Renal Cell Carcinoma: New Insights into the In Vitro Metabolic Impact, Efficacy, and Safety
‡9
1
|
|
919
|
|
|
‡a
evaluationoffreeradicalscavengingandantihemolyticactivitiesof15cydoniaoblongaleafacomparativestudywithgreenteacamelliasinensis
‡A
Evaluation of free radical-scavenging and antihemolytic activities of quince (Cydonia oblonga) leaf: a comparative study with green tea (Camellia sinensis).
‡9
1
|
|
919
|
|
|
‡a
evaluationoffreeradicalscavengingandantihemolyticactivitiesof15
‡A
Evaluation of free radical-scavenging and antihemolytic activities of quince
‡9
1
|
|
919
|
|
|
‡a
environmentalandbiologicalmonitoringofbenzenetolueneethylbenzeneandxylenebtexexposureinresidentslivingneargasstations
‡A
Environmental and biological monitoring of benzene, toluene, ethylbenzene and xylene (BTEX) exposure in residents living near gas stations
‡9
1
|
|
919
|
|
|
‡a
discriminationbetweenthehumanprostatenormalandcancercellexometabolomebygcms
‡A
Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS.
‡9
1
|
|
919
|
|
|
‡a
chiralenantioresolutionofcathinonederivativespresentinlegalhighsandenantioselectivityevaluationoncytotoxicityof34methylenedioxypyrovaleronemdpv
‡A
Chiral enantioresolution of cathinone derivatives present in "legal highs", and enantioselectivity evaluation on cytotoxicity of 3,4-methylenedioxypyrovalerone (MDPV)
‡9
1
|
|
919
|
|
|
‡a
hallucinogenicworldoftryptaminesanupdatedreview
‡A
The hallucinogenic world of tryptamines: an updated review
‡9
1
|
|
919
|
|
|
‡a
metabolicsignatureofmethyloneinprimarymousehepatocytesatsubtoxicconcentrations
‡A
Metabolic signature of methylone in primary mouse hepatocytes, at subtoxic concentrations
‡9
1
|
|
919
|
|
|
‡a
toxicometabolomicssmallmoleculestoanswerbigtoxicologicalquestions
‡A
Toxicometabolomics: Small Molecules to Answer Big Toxicological Questions
‡9
1
|
|
919
|
|
|
‡a
invivotoxicometabolomicsrevealsmultiorganandurinemetabolicchangesinmiceuponacuteaexposuretohumanrelevantdosesof34methylenedioxypyrovaleronemdpv
‡A
In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV)
‡9
1
|
|
919
|
|
|
‡a
updateon1benzylpiperazinebzppartypills
‡A
Update on 1-benzylpiperazine (BZP) party pills.
‡9
1
|
|
919
|
|
|
‡a
invivotoxicometabolomicsrevealsmultiorganandurinemetabolicchangesinmiceuponacuteexposuretohumanrelevantdosesof34methylenedioxypyrovaleronemdpv
‡A
In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV)
‡9
1
|
|
919
|
|
|
‡a
biomarkerdiscoveryinhumanprostatecanceranupdateinmetabolomicsstudies
‡A
Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies
‡9
1
|
|
919
|
|
|
‡a
biologicalactivitiesofportuguesepropolisprotectionagainstfreeradicalinducederythrocytedamageandinhibitionofhumanrenalcancercellgrowthinvitro
‡A
Biological activities of Portuguese propolis: protection against free radical-induced erythrocyte damage and inhibition of human renal cancer cell growth in vitro.
‡9
1
|
|
919
|
|
|
‡a
analysisofvolatilehumanurinarymetabolomebysolidphasemicroextractionincombinationwithgaschromatographymassspectrometryforbiomarkerdiscoveryapplicationinapilotstudytodiscriminatepatientswithrenalcellcarcinoma
‡A
Analysis of volatile human urinary metabolome by solid-phase microextraction in combination with gas chromatography–mass spectrometry for biomarker discovery: Application in a pilot study to discriminate patients with renal cell carcinoma
‡9
1
|
|
919
|
|
|
‡a
volatilemetabolomicsignatureofbladdercancercelllinesbasedongaschromatographymassspectrometry
‡A
Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography–mass spectrometry
‡9
1
|
|
919
|
|
|
‡a
καρκινωμανεφρικωνκυτταρωνμιακριτικηαναλυσημεταβολικωνβιοδεικτωνπουπροκυπτουναποτατρεχονταμοντελασυστηματων
‡A
Καρκίνωμα νεφρικών κυττάρων: μια κριτική ανάλυση μεταβολικών βιοδεικτών που προκύπτουν από τα τρέχοντα μοντέλα συστημάτων.
‡9
1
|
|
919
|
|
|
‡a
adrenalineandreactiveoxygenspecieselicitproteomeandenergeticmetabolismmodificationsinfreshlyisolatedratcardiomyocytes
‡A
Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes
‡9
1
|
|
919
|
|
|
‡a
adipokinegenesinglenucleotidepolymorphismsinportugueseobeseadolescentsassociationswithplasmaconcentrationsofadiponectinresistinil6il1βandtnfα
‡A
Adipokine Gene Single-Nucleotide Polymorphisms in Portuguese Obese Adolescents: Associations with Plasma Concentrations of Adiponectin, Resistin, IL-6, IL-1β, and TNF-α.
‡9
1
|
|
919
|
|
|
‡a
rapidandsimpleprocedurefortheestablishmentofhumannormalandcancerrenalprimarycellculturesfromsurgicalspecimens
‡A
A rapid and simple procedure for the establishment of human normal and cancer renal primary cell cultures from surgical specimens.
‡9
1
|
|
919
|
|
|
‡a
panelofurinaryvolatilebiomarkersfordifferentialdiagnosisofprostatecancerfromotherurologicalcancers
‡A
A Panel of Urinary Volatile Biomarkers for Differential Diagnosis of Prostate Cancer from Other Urological Cancers
‡9
1
|
|
919
|
|
|
‡a
34methylenedioxymethamphetaminehepatotoxicityundertheheatstressconditionnovelinsightsfrominvitrometabolomicstudies
‡A
3,4-Methylenedioxymethamphetamine Hepatotoxicity under the Heat Stress Condition: Novel Insights from in Vitro Metabolomic Studies
‡9
1
|
|
996
|
|
|
‡2
BLBNB|001070224
|
|
996
|
|
|
‡2
NTA|393668983
|
|
996
|
|
|
‡2
DNB|105648277X
|
|
996
|
|
|
‡2
BLBNB|000582517
|
|
996
|
|
|
‡2
BLBNB|000514113
|
|
996
|
|
|
‡2
PTBNP|1740640
|
|
996
|
|
|
‡2
PTBNP|250784
|
|
996
|
|
|
‡2
BLBNB|000629918
|
|
996
|
|
|
‡2
PTBNP|1557372
|
|
996
|
|
|
‡2
BLBNB|000629917
|
|
996
|
|
|
‡2
PTBNP|1462774
|
|
996
|
|
|
‡2
LC|n 2013201080
|
|
996
|
|
|
‡2
ISNI|0000000068193815
|
|
996
|
|
|
‡2
ISNI|0000000418453876
|
|
996
|
|
|
‡2
BLBNB|000527190
|
|
996
|
|
|
‡2
PTBNP|235704
|
|
996
|
|
|
‡2
ISNI|0000000070439079
|
|
996
|
|
|
‡2
SUDOC|250514478
|
|
996
|
|
|
‡2
LC|no2004124047
|
|
996
|
|
|
‡2
RERO|A016723973
|
|
996
|
|
|
‡2
BLBNB|000392236
|
|
996
|
|
|
‡2
ISNI|0000000067818529
|
|
996
|
|
|
‡2
PTBNP|1849700
|
|
996
|
|
|
‡2
PTBNP|1560626
|
|
996
|
|
|
‡2
ISNI|0000000047771006
|
|
996
|
|
|
‡2
PTBNP|178845
|
|
996
|
|
|
‡2
ISNI|0000000048984476
|
|
996
|
|
|
‡2
NUKAT|n 2018174175
|
|
996
|
|
|
‡2
ISNI|0000000373468184
|
|
996
|
|
|
‡2
SUDOC|081582374
|
|
996
|
|
|
‡2
PTBNP|201718
|
|
996
|
|
|
‡2
BLBNB|000265610
|
|
996
|
|
|
‡2
PTBNP|227562
|
|
996
|
|
|
‡2
PTBNP|713474
|
|
996
|
|
|
‡2
PTBNP|225507
|
|
996
|
|
|
‡2
ISNI|0000000067546180
|
|
996
|
|
|
‡2
ISNI|000000006769751X
|
|
996
|
|
|
‡2
PTBNP|522932
|
|
996
|
|
|
‡2
ISNI|0000000067329485
|
|
996
|
|
|
‡2
ISNI|0000000068399821
|
|
996
|
|
|
‡2
BIBSYS|4081062
|
|
996
|
|
|
‡2
LC|n 2005178331
|
|
996
|
|
|
‡2
LC|n 84027645
|
|
996
|
|
|
‡2
ISNI|0000000079929322
|
|
996
|
|
|
‡2
BLBNB|000591104
|
|
996
|
|
|
‡2
ISNI|0000000066293839
|
|
996
|
|
|
‡2
PTBNP|224788
|
|
996
|
|
|
‡2
LC|n 83314438
|
|
996
|
|
|
‡2
BLBNB|001522191
|
|
996
|
|
|
‡2
PTBNP|1911991
|
|
996
|
|
|
‡2
CAOONL|ncf11713804
|
|
996
|
|
|
‡2
ISNI|0000000034871569
|
|
996
|
|
|
‡2
BLBNB|000490073
|
|
996
|
|
|
‡2
PTBNP|122001
|
|
996
|
|
|
‡2
LC|n 93011700
|
|
996
|
|
|
‡2
PTBNP|1211873
|
|
996
|
|
|
‡2
ISNI|0000000112402777
|
|
996
|
|
|
‡2
PTBNP|1373562
|
|
996
|
|
|
‡2
BLBNB|000568906
|
|
996
|
|
|
‡2
LC|no2003110418
|
|
996
|
|
|
‡2
NTA|327775106
|
|
996
|
|
|
‡2
PTBNP|1765888
|
|
996
|
|
|
‡2
ISNI|0000000069392576
|
|
996
|
|
|
‡2
PTBNP|1756918
|
|
996
|
|
|
‡2
PTBNP|38702
|
|
996
|
|
|
‡2
ISNI|0000000068007314
|
|
996
|
|
|
‡2
ISNI|0000000044690155
|
|
996
|
|
|
‡2
ISNI|000000006972290X
|
|
996
|
|
|
‡2
LC|n 2021251593
|
|
996
|
|
|
‡2
LC|n 2007214432
|
|
996
|
|
|
‡2
NTA|267654596
|
|
996
|
|
|
‡2
ISNI|0000000070619416
|
|
996
|
|
|
‡2
ISNI|0000000069101142
|
|
996
|
|
|
‡2
ISNI|0000000068492436
|
|
996
|
|
|
‡2
PTBNP|156371
|
|
996
|
|
|
‡2
PTBNP|37983
|
|
996
|
|
|
‡2
PTBNP|270863
|
|
996
|
|
|
‡2
SUDOC|14618579X
|
|
996
|
|
|
‡2
ISNI|0000000419558055
|
|
996
|
|
|
‡2
PTBNP|150575
|
|
996
|
|
|
‡2
DNB|1075212049
|
|
996
|
|
|
‡2
PTBNP|976006
|
|
996
|
|
|
‡2
LC|n 87152187
|
|
996
|
|
|
‡2
BAV|495_15022
|
|
996
|
|
|
‡2
BAV|495_15023
|
|
996
|
|
|
‡2
PTBNP|160149
|
|
996
|
|
|
‡2
NUKAT|nx2023711904
|
|
996
|
|
|
‡2
BLBNB|000469459
|
|
996
|
|
|
‡2
PTBNP|1543428
|
|
996
|
|
|
‡2
DNB|1250360838
|
|
996
|
|
|
‡2
NTA|353729000
|
|
996
|
|
|
‡2
RERO|A000029335
|
|
996
|
|
|
‡2
ISNI|0000000079817902
|
|
996
|
|
|
‡2
LC|n 2021252639
|
|
996
|
|
|
‡2
PTBNP|224959
|
|
996
|
|
|
‡2
ISNI|0000000069613770
|
|
996
|
|
|
‡2
ISNI|0000000103258443
|
|
996
|
|
|
‡2
BLBNB|000368219
|
|
996
|
|
|
‡2
PTBNP|154949
|
|
996
|
|
|
‡2
ISNI|0000000080197149
|
|
996
|
|
|
‡2
PTBNP|154293
|
|
996
|
|
|
‡2
NTA|104145471
|
|
996
|
|
|
‡2
ISNI|000000007021438X
|
|
996
|
|
|
‡2
LC|n 2015237657
|
|
996
|
|
|
‡2
ISNI|0000000070834079
|
|
996
|
|
|
‡2
ISNI|0000000070817121
|
|
996
|
|
|
‡2
BLBNB|000220120
|
|
996
|
|
|
‡2
ISNI|0000000068002943
|
|
996
|
|
|
‡2
BLBNB|000539831
|
|
996
|
|
|
‡2
BLBNB|001491380
|
|
996
|
|
|
‡2
PTBNP|1421358
|
|
996
|
|
|
‡2
BLBNB|000585158
|
|
996
|
|
|
‡2
BIBSYS|4002898
|
|
996
|
|
|
‡2
BLBNB|001028123
|
|
996
|
|
|
‡2
ISNI|0000000033016704
|
|
996
|
|
|
‡2
PTBNP|135032
|
|
996
|
|
|
‡2
LC|n 2017250517
|
|
996
|
|
|
‡2
LC|n 2007214778
|
|
996
|
|
|
‡2
DNB|1048081443
|
|
996
|
|
|
‡2
DNB|129522333
|
|
996
|
|
|
‡2
PTBNP|195410
|
|
996
|
|
|
‡2
BLBNB|001541383
|
|
996
|
|
|
‡2
PTBNP|37919
|
|
996
|
|
|
‡2
BLBNB|000629963
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
